Keyphrases
Vaccine Candidate
100%
Trypanosoma Cruzi (T. cruzi)
100%
Trypanosoma Cruzi Infection
100%
Immunopathology
100%
Antibody Response
33%
Immunoglobulin
33%
Infected Mice
33%
Challenge Infection
33%
Health Problems
16%
United States
16%
T Cell Response
16%
Age of Infection
16%
Chronic Disease
16%
Plasmid
16%
Mouse Model
16%
Etiological Agents
16%
Emerging Infectious Diseases
16%
Infectious Diseases
16%
Interleukin-12 (IL-12)
16%
Novel Vaccines
16%
Quantitative PCR
16%
Tumor Necrosis Factor-α
16%
Gene-specific
16%
Latin America (LATAM)
16%
Granulocyte Colony-stimulating Factor (G-CSF)
16%
Infiltration
16%
Chagas Disease
16%
T. Cruzi Infection
16%
Bioinformatics Methods
16%
Preclinical Animal Models
16%
Vaccine Effectiveness
16%
Interferon-α (IFN-α)
16%
Parasite Burden
16%
Unvaccinated
16%
Disease Development
16%
Interferon-γ
16%
Interferon Production
16%
Acute Phase
16%
C57BL
16%
Chronic Phase
16%
Expression Plasmid
16%
Inflammatory Infiltrate
16%
Splenocytes
16%
Sequence Database
16%
IgG1
16%
18S rRNA
16%
IgG1 Antibody
16%
Computational Bioinformatics
16%
Immunology and Microbiology
Vaccine Efficacy
100%
Mouse
100%
Immunopathology
100%
Chagas Disease
100%
Antibody Response
50%
Plasmid
50%
Immunoglobulin G2b
50%
T Cell
25%
Cytokine
25%
Mouse Model
25%
interferon
25%
Infectious Disease
25%
Experimental Mouse
25%
Isotype
25%
Trypanosoma Cruzi
25%
Parasite Load
25%
Real Time Polymerase Chain Reaction
25%
Tumor Necrosis Factor Alpha
25%
Granulocyte Macrophage Colony-Stimulating Factor
25%
Interferon Production
25%
C57BL 6 Mouse
25%
Sequence Database
25%
Interferon Gamma
25%
Interleukin 12
25%
Splenocyte
25%
RNA Gene
25%
Immunoglobulin G1
25%
Immunoglobulin G1 Antibody
25%